MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Immuno-Oncology, Immunotherapy
Alpine Immune Sciences, Inc. (NASDAQ: ALPN)
Organization & Developments: Alpine Immune Sciences
Parents
Alpine Immune Sciences, Inc. (NASDAQ: ALPN)
Children
2019: Alpine Immune Sciences: A New Name On The Radar - Alpine Immune Sciences, Inc. (NASDAQ:ALPN)
2020: Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
2020: Alpine: Is This A Young Oak Tree?
2022: Alpine bails on phase 1 cancer asset after 2nd patient death reported in Keytruda combo study
2022: Alpine: Ramifications Of The Davoceticept Termination_ seekingalpha.com
2024: Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug
2024: Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement
2024: Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse
2024: Vertex To Buy Alpine Immune - Why This Deal Feels Slightly 'Vanilla'
2024: What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences
Jumps
Finance & Acquisitions: Alpine Immune Sciences
Key People: Alpine Immune Sciences